Reply to: Does MRI Restaging of Rectal Cancer After Chemoradiotherapy Actually Permit a Change in Surgical Management?

Affiliations

¹ Pelican Cancer Foundation, Basingstoke, United Kingdom, Wessex School of Surgery, Basingstoke, United Kingdom Pelican Cancer Foundation, Basingstoke, United Kingdom, North Hampshire Hospital, Basingstoke, United Kingdom Dresden-Friedrichstadt General Hospital, Dresden, Germany Pathology and Tumor Biology, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, United Kingdom Salisbury District Hospital, Salisbury, United Kingdom Vivantes im Friedrichshain, Berlin, Germany Pathology and Tumor Biology, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, United Kingdom Pelican Cancer Foundation, Basingstoke, United Kingdom Royal Marsden NHS Foundation Trust, London, United Kingdom Aarhus University Hospital, Aarhus, Denmark Aarhus University Hospital Aarhus, Denmark Frimley Park Hospital, Frimley, United Kingdom Pelican Cancer Foundation, Basingstoke, United Kingdom Academic Department for Radiology, Royal Marsden Hospital, Sutton, United Kingdom.

Comment

Nick J Battersby et al. Ann Surg. 2017 Dec.

. 2017 Dec;266(6):e116-e118.

doi: 10.1097/SLA.0000000000001791.

¹ Pelican Cancer Foundation, Basingstoke, United Kingdom, Wessex School of Surgery, Basingstoke, United Kingdom Pelican Cancer Foundation, Basingstoke, United Kingdom, North Hampshire Hospital, Basingstoke, United Kingdom Dresden-Friedrichstadt General Hospital, Dresden, Germany Pathology and Tumor Biology, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, United Kingdom Salisbury District Hospital, Salisbury, United Kingdom Vivantes im Friedrichshain, Berlin, Germany Pathology and Tumor Biology, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, United Kingdom Pelican Cancer Foundation, Basingstoke, United Kingdom Royal Marsden NHS Foundation Trust, London, United Kingdom Aarhus University Hospital, Aarhus, Denmark Aarhus University Hospital Aarhus, Denmark Frimley Park Hospital, Frimley, United Kingdom Pelican Cancer Foundation, Basingstoke, United Kingdom Academic Department for Radiology, Royal Marsden Hospital, Sutton, United Kingdom.

No abstract available

Comment on

Prospective Validation of a Low Rectal Cancer Magnetic Resonance Imaging Staging System and Development of a Local Recurrence Risk Stratification Model: The MERCURY II Study.
Battersby NJ, How P, Moran B, Stelzner S, West NP, Branagan G, Strassburg J, Quirke P, Tekkis P, Pedersen BG, Gudgeon M, Heald B, Brown G; MERCURY II Study Group. Battersby NJ, et al. Ann Surg. 2016 Apr;263(4):751-60. doi: 10.1097/SLA.0000000000001193. Ann Surg. 2016. PMID: 25822672
Does MRI Restaging of Rectal Cancer After Chemoradiotherapy Actually Permit a Change in Surgical Management?
Smith FM, Rooney P, Farrell C. Smith FM, et al. Ann Surg. 2017 Dec;266(6):e104-e105. doi: 10.1097/SLA.0000000000001789. Ann Surg. 2017. PMID: 27232257 No abstract available.